CLOVER HEALTH INVESTMENTS, CORP. /DE·4

Jul 8, 8:00 PM ET

Reynoso Jamie L. 4

4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jul 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Clover Health (CLOV) CEO Jamie Reynoso Sells 2,384 Shares

What Happened
Jamie L. Reynoso, listed as CEO, Medicare Advantage at Clover Health Investments, Corp. (CLOV), disposed of 2,384 shares on July 8, 2026. The shares were sold at $4.68 each for a total reported value of $11,157. This was a sale (not a purchase), which many retail investors treat as routine insider selling unless other context suggests otherwise.

Key Details

  • Transaction date: 2026-07-08 (reported on Form 4 filed 2026-07-09).
  • Transaction type and code: Sale (S); reported as "open market or private sale."
  • Price and quantity: 2,384 shares at $4.68 per share; total value $11,157.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: Sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.
  • Timeliness: Filing appears timely (transaction date 7/8, Form 4 filed 7/9), not marked late.

Context
A 10b5-1 plan lets insiders sell pre-scheduled trades and typically indicates the sale was pre-arranged rather than a spontaneous judgment about the stock. Small-dollar sales like this ( ~$11k ) are common and, by themselves, are not strong indicators of management sentiment.

Insider Transaction Report

Form 4
Period: 2026-07-08
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
  • Sale

    Class A Common Stock

    [F1]
    2026-07-08$4.68/sh2,384$11,1572,832,598 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
Signature
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso|2026-07-09

Documents

1 file
  • 4
    wk-form4_1783629938.xmlPrimary

    FORM 4